IMO and port state inspection authorities set pragmatic
While the number of physical on-board ship inspections has reduced considerably during the COVID-19 pandemic, in order to protect both port State control officers and seafarers, the regimes continue to work to target high-risk ships which may be substandard, IMO said in its release.
The port State control (PSC) regimes which carry out inspections onboard ships to monitor and enforce compliance with international regulations have highlighted their commitment to ensuring shipping continues to trade safely, securely and efficiently during the coronavirus pandemic, while respecting the important role of seafarers as key workers and protecting the environment.
Representatives of the 10 Port State Control regimes which cover the world's oceans met on Wednesday (8 April) in an online video meeting called by the International Maritime Organization (IMO).
The port State control regimes reported that while the number of physical on-board ship inspections has reduced considerably, in order to protect both port State control officers and seafarers, the regimes continue to work to target high-risk ships which may be substandard.
The port State control regimes reported taking a "pragmatic, practical and flexible" approach, recognizing that exemptions, waivers and extensions to certificates have been granted by many flag States. The PSC regimes expressed a general desire for such practices to be standardized and harmonized.
The PSC regimes agreed on the need to work together to develop harmonized port State control practices and policies to ensure a consistent approach across the world and also welcomed the coordinating role of IMO.
Many IMO Member States, as flag States, have communicated information to IMO on their guidance in relation to certificate extensions and related matters (available on the IMO page here). Some of the port State control regimes have already issued guidance and information on conducting ship inspections during the COVD-19 pandemic. These will also be shared on the IMO website.
IMO Secretary-General Kitack Lim reiterated his message that the maritime industry continues to be a vital artery for the global economy and highlighted the need for all involved to work collaboratively to address practical issues caused by the unprecedented global situation. He welcomed the prevailing spirit of cooperation, collaboration and solidarity in these challenging times – when shipping is more important than ever in the global supply chain.
In a joint statement, the port State control regimes and IMO highlighted the unprecedented impact of the COVID-19 crisis and recognized the need to maintain crucial sea trade supply chains, including the flow of vital medical supplies, critical agricultural products, and other goods and services.
"The respective roles of flag States and port States to solve this crisis, in terms of supporting maritime trade, are paramount, and can also be significantly assisted by the industry. At the same time, the safety of life at sea, the protection of the marine environment and the respect of seafarers as keyworkers must remain shared priorities," the statement said.
On the invitation by the Secretary-General, the meeting on PSC inspections on during the COVID-19 pandemic was attended by representatives of the 10 Port State Control (PSC) regimes, namely the United States Coast Guard, the Viña del Mar Agreement and the Abuja, Black Sea, Caribbean, Indian Ocean, Mediterranean, Paris, Riyadh and Tokyo Memoranda of Understanding (MoUs) on port State control, as well as from the IMO Secretariat.
What artificial meat can bring us?
2026-08-19
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Pfizer's paxlovid reduces the risk of COVID-19 by 26%
-
The battle between Pfizer and Gilead over COVID-19 drugs will continue
-
1200 cases were newly prescribed by Junshi Biologic for mild to moderate disease
-
Twenty-five COVID-19 Vaccines In China Enter Stages Of Clinical Trials
-
Pfizer to Increase Production Capacity of COVID-19 Oral Drugs, Invest 120 Million US Dollars
-
Anke Bio and Afana Collaborate on mRNA Vaccines for Mutant Strains Such as COVID-19 Omicron
-
As Low as $25/session! Pfizer's COVID-19 Oral Drug Paxlovid Generic Drug Price Released
-
Survey On Corona Deaths By Country
-
COVID-19 Drug Remdesivir Approved for Infants And Young Children
-
Roche's Q1 Performance Increases by 10%, And Total Revenue for the Year May Slow Down Due to COVID-19, Biosimilar Competition
Recommend Reading
-
Aekyung Chemical Plans to Sell Its Ningbo Subsidiary
-
Metso Expands Wear Parts Capacity in China with New Rubber Factory in Quzhou
-
Pharma’s Tightrope in 2026: Safety, Competition and the Future of Obesity Treatment Innovation
-
Cheap Sugar, Costly Lives: WHO Pushes Governments Toward a New Era of Health Taxes
-
Singapore Orders Nestlé Formula Recall as Infant Safety Comes Under the Spotlight
-
This Week, the Price of Polyester Bottle Chips First Increased and Then Decreased, Falling Within the Week
-
This Week's PVC Market Shows Narrow Range Fluctuations (1.12-16)
-
Industry inventory accumulation pushes acrylonitrile prices to five-year low in China
-
Butadiene Rubber Market Prices Surge Sharply
-
Construction Start Boosts Costs; January Isooctanol Prices Show Volatile Rise